Paroxysmal Nocturnal Hemoglobinuria Epidemiology Forecast to 2030: Two Roads Diverge - Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria - ResearchAndMarkets.com

·2 min read

The "Paroxysmal Nocturnal Hemoglobinuria - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This 'Paroxysmal nocturnal hemoglobinuria (PNH) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of the historical and forecasted epidemiology of PNH in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Paroxysmal nocturnal hemoglobinuria: Epidemiology

The PNH epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical and forecasted PNH epidemiology segmented as the Total diagnosed prevalent cases of Paroxysmal Nocturnal Hemoglobinuria and Gender-specific Cases of PNH. The report includes the prevalent scenario of PNH in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.

Key Topics Covered:

1. Key Insights

2. Paroxysmal Nocturnal Hemoglobinuria (PNH): Market Overview at a Glance

2.1. Market Share (%) Distribution of PNH in 2017

2.2. Market Share (%) Distribution of PNH in 2030

3. Organizations

4. Executive Summary

5. Disease Overview: Paroxysmal Nocturnal Hemoglobinuria (PNH)

5.1. Clinical forms of PNH

5.2. Clinical manifestations

5.3. Pathophysiology of PNH

5.4. Diagnosis

5.4.1. Differential diagnosis

6. Epidemiology and Patient Population

6.1. Key Findings

6.2. Total Diagnosed Prevalence of PNH in 7MM

6.3. Epidemiology of PNH in 7MM

6.3.1. Assumptions and Rationale

6.4. The United States

6.4.1. Total Diagnosed Prevalence of PNH in the United States

6.4.2. Gender-specific Cases of PNH in the United States

6.5. Germany

6.6. Italy

6.7. France

6.8. Spain

6.9. The United Kingdom

6.10. Japan

7. Treatment and Management

8. SWOT Analysis

9. Case Studies

9.1. Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient

9.2. Two Roads Diverge: Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

10. KOL Views

11. Bibliography

12. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/k3dsw3

View source version on businesswire.com: https://www.businesswire.com/news/home/20210415005578/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900